SCHEMBL18007157

SCHEMBL18007157

CCCCCCCCCc1ccc(-c2cnc3[nH]ccc3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 4/20 0.56
▸ CDK8 P49336 5/20 0.55
▸ AXL P30530 2/20 0.55
▸ FLT3 P36888 7/20 0.54
▸ PIK3CD O00329 1/20 0.54
▸ PIK3CA P42336 1/20 0.54
▸ PIK3CB P42338 1/20 0.54
▸ PIK3CG P48736 1/20 0.54
▸ FGFR1 P11362 2/20 0.47
▸ KDR P35968 2/20 0.47
▸ BRD4 O60885 1/20 0.47
▸ PLK4 O00444 1/20 0.47
▸ CHEK1 O14757 1/20 0.47
▸ PDPK1 O15530 1/20 0.47
▸ DYRK3 O43781 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ ROCK2 O75116 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ ABL1 P00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3263731 0.83 KDR (0.61) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL14365346 0.83 RIPK1 (0.65) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL28504617 0.79 FGFR1 (0.67) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL19891723 0.79 KDR (0.62) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL4831501 0.76 CDK8 (0.81) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL858559 0.76 RIPK1 (0.58) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL15871324 0.75 RIPK1 (0.71) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL14365329 0.75 RIPK1 (0.61) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL13854149 0.75 RIPK1 (0.61) RIPK1CDK8AXLFLT3PIK3CD
SCHEMBL21045468 0.74 FLT3 (0.52) RIPK1CDK8FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288213-A1 SYSTEMS BASED ON 5-BROMO-7-AZAINDOLE DERIVATIVES AS FUTURE SOLID EMITTERS CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2019-09-19 — — US disclosed
EP-3466947-A1 SYSTEMS BASED ON 5-BROMO-7-AZAINDOLE DERIVATIVES AS FUTURE SOLID EMITTERS Consejo Superior De Investigaciones Científicas (ES) 2019-04-10 — — EP disclosed
WO-2016132006-A1 ORGANOGEL BASED ON SELF-ASSEMBLED 5-(4-NONYLPHENYL)-7-AZAINDOLES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2016-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288213-A1 SYSTEMS BASED ON 5-BROMO-7-AZAINDOLE DERIVATIVES AS FUTURE SOLID EMITTERS AOX1, BRI3BP, ALDH1A2 RIPK1 4002/4885CDK8 1315/4885AXL 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback